Partner at Chaparral Medical Group in Pomona/ Claremont/Rancho Cucamonga.
Pulmonology
Dr. Heather L. Davis, MD
|
|
Give Review
Heather L. Davis, MD practices Pulmonology. She went to medical school at Keck School of Medicine of USC. Keck School of Medicine of USC is ranked 31 in research and 72 in primary care medicine Heather Davis is a published physician. She has 32 papers published. The most current publication "Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909." She accepts all Medicare patients.
Publications
- Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trial.
- Medicine and the arts. Sickle cell vision: A patient's photographic illustration of coping [excerpt] by Heather L. Davis. Commentary.
- Novel vaccines and adjuvant Systems: the utility of animal models for predicting immunogenicity in humans.
- Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with Chronic hepatitis C virus.
- Enhanced HIV-1 specific immune response by CpG ODN and HIV-1 immunogen-pulsed dendritic cells confers protection in the Trimera murine model of HIV-1 infection.
- Induction of Systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG olig...
- Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
- Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challenge.
- Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal ...
- Immunization with the Chlamydia trachomatis mouse Pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immu...
- Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain.
- CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection.
- Enhancement of functional antibody responses to AMA1-C1/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide.
- Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909.
- A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.
- A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.
- DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice.
- Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell response...
- Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response.
- Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
- Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV Chronic carriers.
- Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.
- TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).
- Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.
- Biodistribution and metabolism of immunostimulatory oligodeoxynucleotide CPG 7909 in mouse and rat tissues following subcutaneous administration.
- The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.
- CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice.
- Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
- Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodeoxynucleotides and resiquimod (R-848).
- CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.
- Safety, pharmacokinetics and immune effects in normal volunteers of CPG 10101 (ACTILON), an investigational synthetic toll-like receptor 9 agonist.
Schools
Keck School Of Medicine Of The Univ Of Southern California
Lacampusc Med Center
Lacampusc Med Cemter
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asthma
- Atelectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
- Sleep Medicine
Accepted Insurances
Education
-
University of Southern California - LAC+USC Medical Center -
Keck School of Medicine of USC
Hospital
-
Pomona Valley Hospital Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Joseph Hourany, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rohinder K. Sandhu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elbert K. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Owais A. Zaidi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James F. Lineback, MD |
|
|
Dr. Gurbinder S. Sadana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica M. Adkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Subhash C. Varshney, MB
This Doctor is OpenDoctor Recommended.
|